High dose 131I therapy for the treatment of hyperthyroidism caused by Graves' disease

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 3, 2002, Pages 1073-1077

  Alexander, Erik K ^a   Larsen, P Reed ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; PROPYLTHIOURACIL; THIAMAZOLE; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; EUTHYROIDISM; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; THYROID FUNCTION TEST; THYROID WEIGHT; THYROTOXICOSIS; THYROXINE BLOOD LEVEL; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; ANTITHYROID AGENTS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; IODINE RADIOISOTOPES; MALE; METHIMAZOLE; MIDDLE AGED; PROPYLTHIOURACIL; RETREATMENT; RETROSPECTIVE STUDIES; THYROTOXICOSIS; TREATMENT OUTCOME;

EID: 0036962179     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.3.1073     Document Type: Article

References (29)

1. Solomon B, Glinoer D, Lagasse R, Wartofsky LN 1990 Current trends in the management of Graves' disease. J Clin Endocrinol Metab 70:1518-1524
2. 131iodine activity. Results from a prospective, randomized, multicentre study. Eur J Clin Invest 25:186-193
3. Beierwaltes WHN 1978 The treatment of hyperthyroidism with iodine-131. Semin Nucl Med 8:95-103
4. Shapiro BN 1993 Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 years? J Nucl Med 34:1638-1641
5. Safa AM, Skillern PGN 1975 Treatment of hyperthyroidism with a large initial dose of sodium iodide I 131. Arch Intern Med 135:673-675
6. Scott GR, Forfar JC, Toft ADN 1984 Graves' disease and atrial fibrillation: the case for even higher doses of therapeutic iodine-131. Br Med J 289:399-400
7. Kendall-Taylor P, Keir MJ, Ross WMN 1984 Ablative radioiodine therapy for hyperthyroidism: long term follow up study. Br Med J 289:361-363
8. Franklyn JA, Daykin J, Drolc Z, Farmer M, Sheppard MCN 1991 Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf) 34:71-76
9. Nordyke RA, Gilbert FI, Number JR 1991 Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease. J Nucl Med 32:411-416
10. Cevallos JL, Hagen GA, Maloof F, Chapman EMN 1974 Low-dosage 131-I therapy of thyrotoxicosis (diffuse goiters). A five-year follow-up study. N Engl J Med 290:141-143
11. 131I therapy for Graves' disease. N Engl J Med 311:426-432
12. Berghout A, Wiersinga WM, Smits NJ, Touber JLN 1987 Determinants of thyroid volume as measured by ultrasonography in healthy adults in a non-iodine deficient area. Clin Endocrinol (Oxf) 26:273-280
13. Clark OHN 2000 Surgical anatomy. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid: a fundamental and clinical text, 8th Ed. Philidelphia: Lippincott, Williams & Wilkins
14. Imseis RE, Vanmiddlesworth L, Massie JD, Bush AJ, Vanmiddlesworth NRN 1998 Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 83:685-687
15. Tuttle RM, Patience T, Budd SN 1995 Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 5: 243-247
16. Marcocci C, Gianchecchi D, Masini I, Golia F, Ceccarelli C, Bracci E, Fenzi GF, Pinchera A 1990 A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. J Endocrinol Invest 13:513-520
17. Andrade VA, Gross JL, Maia AL 2001 The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study. J Clin Endocrinol Metab 86:3488-3493
18. Graham GD, Burman KDN 1986 Radioiodine treatment of Graves' disease. An assessment of its potential risks. Ann Intern Med 105:900-905
19. Cunnien AJ, Hay ID, Gorman CA, Offord KP, Scanlon PWN 1982 Radioiodine-induced hypothyroidism in Graves' disease: factors associated. J Nucl Med 23:978-983
20. Williams EDN 1994 Fallout from Chernobyl. Thyroid cancer in children increased dramatically in Belarus [Letter]. Br Med J 309:1298
21. Wise PH, Ahmad A, Burnet RB, Harding PEN 1975 Intentional radioiodine ablation for Graves' disease. Lancet 2:1231-1233
22. Eriksson E, Eriksson K, Wahlberg PN 1985 Treatment of hyperthyroidism with standard doses of radioiodine aiming at ablation. Acta Med Scand 217: 55-60
23. Kaplan MM, Meier DA, Dworkin HJN 1998 Treatment of hyperthyroidism with radioactive iodine. Endocrinol Metab Clin North Am 27:205-223
24. Cooper DS 2000 Treatment of thyrotoxicosis, 8th Ed. Philadelphia: Lippincott, Williams & Wilkins; 691-711
25. Becker DV, Hurley JR 1996 Radioiodine treatment of hyperthyroidism. New York: Williams & Wilkins; 943-958
26. Sawers JS, Toft AD, Irvine WJ, Brown NS, Seth JN 1980 Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis. J Clin Endocrinol Metab 50:226-229
27. Aizawa Y, Yoshida K, Kaise N, Fukazawa H, Kiso Y, Sayama N, Hori H, Abe K 1997 The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis. Clin Endocrinol (Oxf) 46:1-5
28. Gomez N, Gomez JM, Orti A, Gavalda L, Villabona C, Leyes P, Soler J 1995 Transient hypothyroidism after iodine-131 therapy for Grave's disease. J Nucl Med 36:1539-1542
29. 131I treatment protocols for Graves' disease. J Endocrinol Invest 13:111-118